Readmissions after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy—a national population-based study

BACKGROUND: Comprehensive readmission morbidity studies after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are scarce. This study aimed to investigate readmissions and in-hospital morbidity after CRS and HIPEC. METHODS: The national in-hospital patient register w...

Descripción completa

Detalles Bibliográficos
Autores principales: Dranichnikov, Paul, Graf, Wilhelm, Cashin, Peter H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137266/
https://www.ncbi.nlm.nih.gov/pubmed/32252768
http://dx.doi.org/10.1186/s12957-020-01837-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137266/
https://www.ncbi.nlm.nih.gov/pubmed/32252768
http://dx.doi.org/10.1186/s12957-020-01837-4

Ejemplares similares